Cash And Equivalent Cambio Fecha
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amarin USD 270.81M 37.82M 2023-09
BioCryst Pharmaceuticals USD 397.59M 251.38M 2023-09
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Esperion Therapeutics USD 114.83M 23.64M 2023-09
Galectin Therapeutics USD 20.36M 2.4M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Incyte USD 3.21B 13.85M 2023-12
Insmed USD 482.37M 4.74M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Sarepta Therapeutics USD 541.93M 310M 2023-09
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
United Therapeutics USD 1.21B 100M 2023-12



DBV Technologies Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.